ANEL leader's son to cultivate cannabis
- Written by E.Tsiliopoulos
Ilias Kammenos, son of Panos Kammenos, is the declared shareholder of the company Greekkannabis, as evidenced by the documents and the statutes of the private capital company, which he established together with two other persons.
The son of Panos Kammenos, who declared as his adress, the address of the offices of ANEL, at Harokopou str. 2 and Syngrou Avenue, will deal with the company that aims, according to the statutes, to "cultivate, produce, process, manufacture, transport, packaging, distribution and marketing in and outside of Greece of flax, hemp, aromatic plants, seeds, herbs and any other derivative of these substances'.
As stated in the statutes disclosed by bankstersae.blogspot.com, the company's goals include the promotion and advertising of pharmaceuticals, pharmaceutical cannabis, aromatic plants, herbs and cosmetic preparations from these substances.
The company was established in a one-stop service on November 22, 2018, when Panos Kammenos had not left the government and held the post of Minister of National Defense, as ANEL left the government in January 2019.
It is unknown whether the former minister intends to actively engage in the business of his son after his party and himself will not run in the elections.
Related items
-
Couple falls to death from apartment building in Ioannina
-
PM Mitsotakis: Rafale agreement reflects Greece's strategy of a combined foreign and defense policy
-
Exploratory contacts between Greece and Turkey resume on Monday
-
PM Mitsotakis stresses need to speed up EU's vaccines approval process
-
SYRIZA in disarray over support for 17 November murderer
Latest from E.Tsiliopoulos
- Couple falls to death from apartment building in Ioannina
- PM Mitsotakis: Rafale agreement reflects Greece's strategy of a combined foreign and defense policy
- Exploratory contacts between Greece and Turkey resume on Monday
- Former PASOK minister Valyrakis found dead at sea
- PM Mitsotakis stresses need to speed up EU's vaccines approval process